Belden Flat on Precision Optical Award
Shares in Belden Inc. (NYSE: BDC) were little changed at the open Friday. The company, a leading global provider of complete connection solutions, is proud to announce that Precision Optical Technologies, a sub-brand within Belden’s broadband solutions portfolio, has been awarded outstanding honoree status for its OpenPath® PON Extender technology. “After being evaluated by a panel of optical communications and broadband experts,” according to this morning’s news release, “the new OpenPath® PON Extender technology focused on fiber-to-the-home applications was recognized by 2025 Lightwave+BTR Innovation Reviews as among the best in the industry.This awards set recognizes technology developers demonstrating excellence in the optical network and broadband communities. Lightwave+BTR Editor in Chief Sean Buckley expressed his congratulations, stating, “On behalf of the Lightwave+BTR Innovation Reviews, I would like to congratulate Precision on achieving a well-deserved 4.5-star honoree status. This competitive program enables Lightwave+BTR to showcase and applaud the most innovative products, projects, technologies, and programs that significantly impact the industry.”“This award is a testament to Belden’s unwavering commitment to cutting-edge technology and innovation,” said Cary Mullin, VP & GM, Broadband Solutions. “Our proprietary OpenPath® PON Extender is revolutionizing Passive Optical Networks, enabling greater efficiency and reach. We remain dedicated to pioneering broadband solutions that set new industry standards and drive the future of connectivity.”BDC shares dropped seven cents to $107.00
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


